Multiple Emergency Department Presentations of COVID-19-Related Multisystem Inflammatory Syndrome in Children

Abstract

Get full access to this article

View all access options for this article.

References

CDC COVID-19 Response Team. Coronavirus disease 2019 in children—United States, February 12-April 2, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:422-426.

Dong

, et al. Epidemiology of COVID-19 among children in China. Pediatrics. 2020;145:e20200702. doi:10.1542/peds.2020-0702

She

Liu

. COVID-19 epidemic: disease characteristics in children. J Med Virol. 2020;92:747-754. doi:10.1002/jmv.25807

Ludvigsson

. Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr. 2020;109:1088-1095. doi:10.1111/apa.15270

Mahase

. Covid-19: concerns grow over inflammatory syndrome emerging in children. BMJ. 2020;369:m1710. doi:10.1136/bmj.m1710

NYC Health. 2020 Health Alert # 13: pediatric multi-system inflammatory syndrome potentially associated with COVID-19. Published May 4, 2020. Accessed March 15, 2021. https://www1.nyc.gov/assets/doh/downloads/pdf/han/alert/2020/covid-19-pediatric-multi-system-inflammatory-syndrome.pdf

Centers for Disease Control and Prevention. Multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease 2019 (COVID-19). Published May 14, 2020. Accessed March 15, 2021. https://emergency.cdc.gov/han/2020/han00432.asp

Pediatric Intensive Care Society. PICS statement: increased number of reported cases of novel presentation of multi-system inflammatory disease. Published April 27, 2020. Accessed March 15, 2021. https://picsociety.uk/wp-content/uploads/2020/04/PICS-statement-re-novel-KD-C19-presentation-v2-27042020.pdf

Jones

Mills

Suarez

, et al. COVID-19 and Kawasaki disease: novel virus and novel case. Hosp Pediatr. 2020;10:537-540. doi:10.1542/hpeds.2020-0123

10.

Rivera-FigueroaI

Santos

Simpson

Garg

. Incomplete Kawasaki disease in a child with Covid-19. Indian Pediatr. 2020;57:680-681.

11.

Balasubramanian

Nagendran

Ramachandran

Ramanan

. Hyper-inflammatory syndrome in a child with COVID-19 treated successfully with intravenous immunoglobulin and tocilizumab. Indian Pediatr. 2020;57:681-683.

12.

Riphagen

Gomez

Gonzalez-Martinez

Wilkinson

Theocharis

. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020;395:1607-1608. doi:10.1016/S0140-6736(20)31094-1

13.

Royal College of Paediatrics and Child Health. Guidance: paediatric multisystem inflammatory syndrome temporally associated with COVID-19. Published 2020. Accessed March 15, 2021. https://www.rcpch.ac.uk/sites/default/files/2020-05/COVID-19-Paediatric-multisystem-inflammatory syndrome-20200501.pdf

14.

Morand

Urbina

Fabre

. COVID-19 and Kawasaki like disease: the known-known, the unknown-known and the unknown-unknown. Published online May 9, 2020. doi:10.20944/preprints202005.0160.v1

15.

Verdoni

Mazza

Gervasoni

, et al. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 2020;395:1771-1778. doi:10.1016/S0140-6736(20)31103-X

16.

Dinnes

Deeks

Adriano

, et al. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection. Cochrane Database Syst Rev. 2020;(8):CD013705. doi:10.1002/14651858.CD013705

17.

Harrington

Cox

Snowdon

, et al. Comparison of Abbott id now and Abbott m2000 methods for the detection of sars-cov-2 from nasopharyngeal and nasal swabs from symptomatic patients. J Clin Microbiol. 2020;58:e00798-20. doi:10.1128/JCM.00798-20